Current developments in peritoneal glucose transport and sodium-glucose co-transporter 2 inhibitors during peritoneal dialysis

As a novel widely used drug, sodium-glucose co-transporter (SGLT) 2 inhibitor may lower blood glucose in type 2 diabetics through blocking SGLT2 to curtain glucose reabsorption in proximal renal tubular cells. At the same time, this drug may bring significant renal and cardiovascular benefits to bot...

Full description

Saved in:
Bibliographic Details
Main Authors: Fan Yang (Author), Cong-hui Liu (Author), Xiao-qi Wang (Author), Xiao-jing Liu (Author), Ya-nan Shi (Author), Zhong-xin Li (Author)
Format: Book
Published: Editorial Department of Journal of Clinical Nephrology, 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!